A recent ruling by a DC judge has upheld the FDA's drug approval process amid ongoing disputes with pharmaceutical companies. This decision comes as the Third Circuit Court of Appeals has limited trial judges' discretion in granting compassionate release for incarcerated individuals, prompting criticism from lawmakers including Senator Dick Durbin. Durbin expressed disappointment with the Third Circuit's ruling, emphasizing the need for the Supreme Court to maintain judges' ability to exercise discretion based on changes in sentencing law. The Biden administration has also faced legal challenges regarding a law designed to protect patients from surprise medical costs, which has raised questions about future rulemaking and billing disputes. Meanwhile, the 2nd Circuit's recent ruling has drawn ire from gun owners, who argue it undermines their rights in New York, highlighting the significance of judicial appointments in the upcoming elections.